 |
 |
 |
 |
 |
 |
Announcements & Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 25, 2016
TUCSON, Ariz., April 25, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report first-quarter 2016 financial results after market close on Thursday, May 12, 2016....
-
Apr 10, 2016
TUCSON, Ariz., April 10, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today it will present data related to the Accelerate Pheno™ system and Accelerate PhenoTest™
-
Jan 5, 2016
TUCSON, Ariz., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at...
-
Jan 5, 2016
TUCSON, Ariz., Jan. 29, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) ("Accelerate Diagnostics") announced today that the United States District Court for the District of Arizona
-
Dec 15, 2015
TUCSON, Ariz., Dec. 15, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced that it completed a public offering of 6,426,471 shares of common stock today at a previously...
-
Dec 9, 2015
TUCSON, Ariz., Dec. 9, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 5,588,236 shares of its common stock at...
-
Dec 8, 2015
TUCSON, Ariz., Dec. 8, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of $80 million of shares of its...
-
Dec 2, 2015
TUCSON, Ariz., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced positive findings from a multicenter pilot study to evaluate external performance of its ID/AST System and...
-
Dec 1, 2015
TUCSON, Ariz., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced today that Lawrence Mehren, Chief Executive Officer, is scheduled to present a corporate update...
-
Aug 5, 2015
TUCSON, Ariz., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...
-
Jun 30, 2015
TUCSON, Ariz., June 30, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC and CE Mark of...
-
Apr 17, 2015
TUCSON, Ariz., April 17, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant...
-
Mar 23, 2015
TUCSON, Ariz., March 23, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc., an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistant...
-
Mar 16, 2015
TUCSON, Ariz., March 16, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of...
-
Jan 7, 2015
TUCSON, Ariz., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...
-
Nov 3, 2014
TUCSON, Ariz., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...
-
Sep 25, 2014
TUCSON, Ariz., Sept. 25, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...
-
May 2, 2014
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider...
-
Apr 7, 2014
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections,...
-
Jan 31, 2014
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections,...
-
Nov 6, 2013
Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections,...
-
Aug 13, 2013
Accelerate Diagnostics, Inc. (AXDX), announced today that it has completed its previously announced rights offering. Through broad participation from both insiders and non-insider investors, the...
-
Jul 12, 2013
Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections,...
-
Jul 1, 2013
Accelerate Diagnostics, Inc. (AXDX), today announced that it has appointed Pete Bantock to the position of Chief Commercial Officer, effective today. Most recently Pete was Sr. Vice President and...
-
Jul 1, 2013
Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today...